Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

825 Intratumoral B7H3:CD3 bispecific T-cell engager drives localized T-cell accumulation in canine sarcoma patients

  • Jason Price1
  • James Olson2
  • Yusuke Suita1
  • Kenneth Brasel1
  • Lisa S Ang1
  • Shelli M Morris1
  • Alison M Williams1
  • Emily J Girard1
  • Steven C Chen1
  • Ian Blumenthal1
  • Natasha M Hottmann3
  • Jennifer Heusser3
4 more authors
  • Drew Mhyre1
  • Cole A DeForest4
  • Peter F Moore5
  • Janean L Fidel3
5 affiliations
  1. 1Seattle Children’s Research Institute, Seattle, WA, USA
  2. 25Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA, USA
  3. 3Washington State University, Pullman, WA, USA
  4. 4University of Washington, Seattle, WA, USA
  5. 5University of California Davis, Davis, CA, USA
Open at sourcePDFDOICite

Related

  1. 1054 Pharmaceutical surgery by design: IV dosed virus ATTR02 enables in-tumor production of a universal bispecific T cell engager to address tumor heterogeneity
    Emma Henderson, Alan Parker, Rahul C Khanolkar +9
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textGenetics & genomicsDOAJ
  2. 902 Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy
    Carsten Müller-Tidow, Hartmut Goldschmidt, Hermann Einsele +16
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  3. CD3-CSPG4 bispecific T cell engager: A novel platform for malignant melanoma therapy
    Xue Lei, Weilan Liu, Zongnian Luo +3
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyOncologyPLOS
  4. The plasma membrane–localized CsMAC9F1 mediates citrate accumulation in citrus fruit
    Yuanyuan Chang, Yuewen Chen, Yushuang Zhao +6
    Horticulture researchPeer-reviewedCC BYFull textPlant biologyEurope PMCPMC
  5. Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies
    Jiahao Ji, Xinyu Zhao, Bin Wang +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{price2026intratumoral,
  title = {{825 Intratumoral B7H3:CD3 bispecific T-cell engager drives localized T-cell accumulation in canine sarcoma patients}},
  author = {Jason Price and James Olson and Yusuke Suita and Kenneth Brasel and Lisa S Ang and Shelli M Morris and Alison M Williams and Emily J Girard and Steven C Chen and Ian Blumenthal and Natasha M Hottmann and Jennifer Heusser and Drew Mhyre and Cole A DeForest and Peter F Moore and Janean L Fidel},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0825},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0825},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 825 Intratumoral B7H3:CD3 bispecific T-cell engager drives localized T-cell accumulation in canine sarcoma patients
AU  - Jason Price
AU  - James Olson
AU  - Yusuke Suita
AU  - Kenneth Brasel
AU  - Lisa S Ang
AU  - Shelli M Morris
AU  - Alison M Williams
AU  - Emily J Girard
AU  - Steven C Chen
AU  - Ian Blumenthal
AU  - Natasha M Hottmann
AU  - Jennifer Heusser
AU  - Drew Mhyre
AU  - Cole A DeForest
AU  - Peter F Moore
AU  - Janean L Fidel
PY  - 2026
DA  - 2026/11/05
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0825
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0825
SN  - 2051-1426
ER  -